Viking Therapeutics Preferred Securities out of Shareholders Equity (Quarterly) Analysis

Viking Therapeutics, Inc. (VKTX)

32.74 -0.38 (-1.15%) USD | NASDAQ | Feb 26, 10:17

View Preferred Securities out of Shareholders Equity (Quarterly) for VKTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	--
Pfizer Inc.	--
Amgen, Inc.	--
Hims & Hers Health, Inc.	--
Regeneron Pharmaceuticals, Inc.	--